🔍
Search Results - clinical+and+disease+specializations+%3e+respiratory+diseases+%3e+acute+respiratory+distress+syndrome
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Breathable Nanomedicine: Inhalable Angiotensin Blockers for Treating COVID-19 and Respiratory Infections
Value Proposition· Provides targeted pulmonary delivery with superior lung pharmacokinetics· Offers mutation-resistant therapeutic action, unlike current vaccines· Reduces risk of progression to severe lung disease in newly diagnosed patients· Applicable to a wide range of respiratory infections and ARDS-related conditions· Enhances...
Published: 3/13/2026
|
Inventor(s):
Jung Soo Suk
,
Daiqin Chen
,
Joe DiCostanzo
,
Axel Lehrer
,
Oreola Donini
Keywords(s):
Category(s):
Clinical and Disease Specializations > Infectious Diseases > Covid-19
,
Clinical and Disease Specializations > Infectious Diseases > Respiratory Infections
,
Clinical and Disease Specializations > Respiratory Diseases
,
Clinical and Disease Specializations > Respiratory Diseases > Acute Respiratory Distress Syndrome
,
Clinical and Disease Specializations > Infectious Diseases
,
Technology Classifications > Therapeutic Modalities
,
Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms
,
Technology Classifications > Therapeutic Modalities > Targets
Therapies to Accelerate Resolution of Acute Lung Inflammation
Acute respiratory distress syndrome (ARDS) is a devastating inflammatory lung disease for which there are no effective targeted therapies. In experimental models of acute lung inflammation and injury, regulatory T cells (Tregs) orchestrate a pro-repair program; Tregs themselves are highly dependent on epigenetic mechanisms such as DNA hypomethylation. ...
Published: 3/12/2026
|
Inventor(s):
Franco D'alessio
,
Landon King
,
Benjamin Singer
,
Neil Aggarwal
Keywords(s):
Acute Respiratory Distress Syndrome
,
Acute Respiratory Distress Syndrome (ARDS)
,
Antagonists/Inhibitors
,
Chemotherapy
,
Disease Indication
,
Immunotherapy
,
Lung Disorders
,
Non-novel
,
Predicted Novelty
,
Repurposed
,
Single
,
Small Molecules
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Therapy Type
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Respiratory Diseases > Acute Respiratory Distress Syndrome
,
Technology Classifications > Therapeutic Modalities
,
Technology Classifications > Therapeutic Modalities > Immunotherapies
,
Technology Classifications > Therapeutic Modalities > Small Molecules
,
Clinical and Disease Specializations > Respiratory Diseases
,
Technology Classifications > Therapeutic Modalities > Repurposed Drugs
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum